BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16750222)

  • 81. A native chemical ligation approach for combinatorial assembly of affibody molecules.
    Lindgren J; Ekblad C; Abrahmsén L; Eriksson Karlström A
    Chembiochem; 2012 May; 13(7):1024-31. PubMed ID: 22532524
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Affinity enhancement of HER2-binding Z(HER2:342) affibody via rational design approach: a molecular dynamics study.
    Ghaffari MA; Zeinali M; Barzegari Asadabadi E; Jamalan M; Jahandideh S
    J Biomol Struct Dyn; 2014 Dec; 32(12):1919-28. PubMed ID: 24125055
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Engineering of affibody molecules for therapy and diagnostics.
    Feldwisch J; Tolmachev V
    Methods Mol Biol; 2012; 899():103-26. PubMed ID: 22735949
    [TBL] [Abstract][Full Text] [Related]  

  • 84. High-affinity binders selected from designed ankyrin repeat protein libraries.
    Binz HK; Amstutz P; Kohl A; Stumpp MT; Briand C; Forrer P; Grütter MG; Plückthun A
    Nat Biotechnol; 2004 May; 22(5):575-82. PubMed ID: 15097997
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Grafting of functional motifs onto protein scaffolds identified by PDB screening--an efficient route to design optimizable protein binders.
    Tlatli R; Nozach H; Collet G; Beau F; Vera L; Stura E; Dive V; Cuniasse P
    FEBS J; 2013 Jan; 280(1):139-59. PubMed ID: 23121732
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Phage-based molecular directed evolution yields multiple tandem human IgA affibodies with intramolecular binding avidity.
    Cao J; Wen ZM; Deng SH; Zhou X; Chen QL; Liao WT; Jiang SH; Jia JA; Qi ZT; Sun SH; Pan W
    J Biotechnol; 2012 Apr; 158(3):120-7. PubMed ID: 21219944
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
    Schlehuber S; Skerra A
    Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Construction and characterization of affibody-Fc chimeras produced in Escherichia coli.
    Rönnmark J; Hansson M; Nguyen T; Uhlén M; Robert A; Ståhl S; Nygren PA
    J Immunol Methods; 2002 Mar; 261(1-2):199-211. PubMed ID: 11861078
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Structure-based design of a photoswitchable affibody scaffold.
    Woloschuk RM; Reed PMM; Jaikaran ASI; Demmans KZ; Youn J; Kanelis V; Uppalapati M; Woolley GA
    Protein Sci; 2021 Dec; 30(12):2359-2372. PubMed ID: 34590762
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Modelling protein-RNA interactions: an electron density study of the guanidinium and formate complexes with RNA bases.
    Rozas I; Alkorta I; Elguero J
    Org Biomol Chem; 2005 Jan; 3(2):366-71. PubMed ID: 15632980
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.
    Löfblom J; Feldwisch J; Tolmachev V; Carlsson J; Ståhl S; Frejd FY
    FEBS Lett; 2010 Jun; 584(12):2670-80. PubMed ID: 20388508
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Functionality of wrapping defects in soluble proteins: what cannot be kept dry must be conserved.
    Fernández A
    J Mol Biol; 2004 Mar; 337(2):477-83. PubMed ID: 15003461
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Structural basis for high-affinity HER2 receptor binding by an engineered protein.
    Eigenbrot C; Ultsch M; Dubnovitsky A; Abrahmsén L; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15039-44. PubMed ID: 20696930
    [TBL] [Abstract][Full Text] [Related]  

  • 94. NMR detection of intermolecular NH.OP hydrogen bonds between guanidinium protons and bisposphonate moieties in an artificial arginine receptor.
    Gschwind RM; Armbrüster M; Zubrzycki IZ
    J Am Chem Soc; 2004 Aug; 126(33):10228-9. PubMed ID: 15315419
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Arginine side chain interactions and the role of arginine as a gating charge carrier in voltage sensitive ion channels.
    Armstrong CT; Mason PE; Anderson JL; Dempsey CE
    Sci Rep; 2016 Feb; 6():21759. PubMed ID: 26899474
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Principal role of large polar residue clusters of RNA-binding proteins in the formation of complexes with RNA].
    Chirgadze IuN; Larionova EA
    Mol Biol (Mosk); 2005; 39(6):1017-31. PubMed ID: 16358739
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rounding up: Engineering 12-membered rings from the cyclic 11-mer TRAP.
    Heddle JG; Yokoyama T; Yamashita I; Park SY; Tame JR
    Structure; 2006 May; 14(5):925-33. PubMed ID: 16698553
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Structural basis for recognition by an in vitro evolved affibody.
    Högbom M; Eklund M; Nygren PA; Nordlund P
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3191-6. PubMed ID: 12604795
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Interaction of arginine, lysine, and guanidine with surface residues of lysozyme: implication to protein stability.
    Shah D; Shaikh AR
    J Biomol Struct Dyn; 2016; 34(1):104-14. PubMed ID: 25730443
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of staphylococcal cell surface display and flow cytometry for postselectional characterization of affinity proteins in combinatorial protein engineering applications.
    Löfblom J; Sandberg J; Wernérus H; Ståhl S
    Appl Environ Microbiol; 2007 Nov; 73(21):6714-21. PubMed ID: 17873070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.